ANORECTIC DRUGS - DRUG POLICY MAKING AT THE STATE LEVEL

被引:6
作者
RICHARD, BW
LASAGNA, L
机构
[1] TUFTS UNIV,CTR STUDY DRUG DEV,BOSTON,MA 02111
[2] TUFTS UNIV,DEPT PSYCHIAT,BOSTON,MA 02111
关键词
D O I
10.1002/j.1552-4604.1988.tb05747.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:395 / 400
页数:6
相关论文
共 11 条
[1]  
CHI KS, 1983, PRESCRIPTION DRUG AB
[2]  
Griffiths RR., 1979, ADV BEHAV PHARMACOL, V2, P163
[3]  
LASAGNA L, 1980, OBESITY, P292
[4]  
PARSONS WB, 1981, CLIN THER, V3, P329
[5]  
Scoville BA, 1973, DHEW NIH PUBLICATION, P441
[6]  
SULLIVAN AC, 1978, INT J OBESITY, V2, P167
[7]   RESTRICTING AMPHETAMINES - WISCONSINS SUCCESS STORY [J].
TREFFERT, DA ;
JORANSON, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (13) :1336-1338
[8]   A DOUBLE-BLIND CLINICAL-TRIAL IN WEIGHT CONTROL - USE OF FENFLURAMINE AND PHENTERMINE ALONE AND IN COMBINATION [J].
WEINTRAUB, M ;
HASDAY, JD ;
MUSHLIN, AI ;
LOCKWOOD, DH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (06) :1143-1148
[9]  
WURTMAN JJ, 1984, J AM DIET ASSOC, V84, P1004
[10]  
1986, NIDA STATISTICAL SER, V16